61 |
The relationship of belief in control and commitment to life to cancer patients' inclination to use unproven cancer therapiesSkinn, Barbara Jean January 1990 (has links)
The purpose of this study was to explore the relationship of belief in control and commitment to life to the adult cancer patient's inclination to use unproven cancer therapies. A convenience sample of 40 lung cancer patients completed the Wallston's Multidimensional Health Locus of Control Scale, Crumbaugh's Purpose in Life Scale, Hiratzka's Alternative Therapy Scale, and a patient information sheet. The majority of participants exhibited a strong internal locus of control orientation and a strong commitment to life. Belief in control, commitment to life, and the degree of inclination to use unproven cancer therapies were not significantly associated. However, age was negatively correlated with inclination to use unproven cancer therapies. The majority of participants had heard of five or more unproven cancer remedies, and exhibited a strong inclination to use these unorthodox therapies. The most frequently used unproven therapies were anti-medicines - imagery, faith-healing, megadose vitamins, and taheebo. The rising popularity of these anti-medicines has been reported in the literature. The findings were discussed in relation
to theoretical expectations, other research studies, and the methodological problems inherent in the study. Implications of the findings for nursing practice, theory, and education were suggested. Recommendations for further nursing research were made. / Applied Science, Faculty of / Nursing, School of / Graduate
|
62 |
The efficacy of a phytotherapeutic complex (Angelica sinensis, Dioscorea villosa, Matricaria chamomilla, Viburnum opulus and Zingiber officinalis) compared with homoeopathic similimum in the treatment of primary dysmenorrhoeaShange, Nondumiso Caroline January 2016 (has links)
Submitted in partial compliance with the requirements of the Master’s Degree in Technology: Homeopathy, Durban University of Technology, Durban, South Africa, 2016. / INTRODUCTION
Dysmenorrhoea is defined as difficult menstrual flow or painful menstruation. Dysmenorrhoea is the most common gynaecological complaint in younger women who present themselves to clinicians.
Primary dysmenorrhoea is defined as painful menstrual cramps without any evident pathology present. It refers to any degree of perceived cramping pain experienced during menstruation. Around 50% of menstruating females suffer from primary dysmenorrhoea. Prevalence decreases with age, with prevalence being highest in the 20 to 24 year old age group. This trial intended to evaluate the effectiveness of a phytotherapeutic complex in the treatment of primary dysmenorrhoea compared to homoeopathic similimum in a 30 cH plussed potency. This study aimed to provide the safe and effective alternative therapy for primary dysmenorrhoea, especially for the population that is contradicted to use the readily available forms of treatments.
TRIAL DESIGN
This double-blind randomised parallel clinical trial, aimed to determine the effectiveness of a phytotherapeutic complex consisting of Angelica sinensis1:10, Dioscorea villosa1:10, Matricaria chamomilla 1:10, Viburnum opulus 1:10, and Zingiber officinalis 1:10 in the treatment of primary dysmenorrhea, compared to homoeopathic similimum in a 30cH plussed potency.
METHODOLOGY
A sample group of 26 participants were voluntarily selected for the study on the basis of an inclusion and exclusion criteria. These participants were then randomly divided into two groups, 17 in the group receiving the phytotherapeutic complex, 8 in the control group receiving the similimum and 1 drop-out. Each participant had to attend a total of four consultations with the researcher over a three month period, at the Durban University of Technology (DUT) Homoeopathic Day Clinic.
At each consultation the participant completed the Moos Menstrual Distress Questionnaire (MDQ) (Appendix B) as well as the Pain Rating Scale (PRS) (Appendix C).
Intra-group analysis was performed using the non-parametric test for analysis of variance: Friedman’s test. Inter-group analysis was conducted using the Mann- Whitney U test for two independent samples.
RESULTS
Results from the intra-group analysis showed that in both groups most measured parameters relating to experience during the previous menstrual flow showed statistically significant reductions in intensity. This is to say that both the group receiving phytotherapy and the group receiving similimum experienced reductions in their symptoms as measured by both the MDQ and the PRS.
Results from the inter-group analysis showed that there is no significant difference between the phytotherapy and similimum group in all symptoms except the water retention category, with regard to symptom perception during the last menstrual flow of the trial.
CONCLUSION
The conclusion reached in this study was that both the phytotherapeutic complex treatment and the homoeopathic similimum treatment were effective at reducing the clinical features of primary dysmenorrhea, but there was no significant difference between the phytotherapy and similimum group in all except the water retention category during the last menstrual period as measured by the MDQ Further, there was no statistically significant difference between groups treated with phytotherapy compared to similimum as measured by the PRS. / M
|
63 |
Potential effect of senna italica on glucose transport receptors - translocation go GLUT4 in NIH-3T3-L1 preadipocytes and C2C12 muscle cellsSegolela, Jane Choene January 2015 (has links)
Thesis (M. Sc. (Biochemistry)) -- University of Limpopo, 2015 / Diabetes mellitus is one of the major diseases worldwide that is life threatening and is reaching an epidemic proportion. The most important approach in reducing the burden of the disease worldwide is to search for effective, low cost hypoglycaemic drugs with fewer side effects. Past experimental evidence confirmed the hypoglycemic activity of many indigenous African medicinal plants. S. italica (Fabaceae family) is widely used by traditional healers to treat a number of diseases such as sexually transmitted diseases and other forms of intestinal complications traditionally. The current study was aimed at evaluating the in vitro effects of root and leaf extracts of S. italica on GLUT4 translocation in NIH-3T3-L1 preadipocytes and C2C12 muscle cells. In order to address the aim of the study various methods were undertaken. The roots and leaves of S. italica collected from Zebediela sub-region of the Limpopo province, South Africa, were ground to fine powder and extracted using acetone, methanol, ethyl acetate and n-hexane. The various extracts of the root and leaf material were subjected to fingerprint profiling using TLC plates and different mobile phases (BEA, CEF, EMW and BAW). The chromatograms were visualized with vanillin-H2SO4 reagent, p-anisaldehyde and iodine vapour. The extracts were assayed for the type of secondary metabolites contained in the studied plant parts using chemical text and by TLC analysis. The total phenolic content of the root and leaf material were also evaluated. Evaluation for antioxidant activity was performed using 0.2% DPPH qualitatively and quantitatively with vitamin C as a positive control. Toxicity study was performed on C2C12 muscle cells using the MTT assay, with Curcumin as a positive control and untreated cells as a negative control. The CC50 values of the acetone root and leaf extracts were determined by linear regression. The effect of acetone root and leaf extracts on glucose uptake by C2C12 muscle cells was evaluated, also on western blot and immunofluorescence for NIH-3T3-L1 preadipocytes. The solvents employed for extraction in this study are commonly used to extract various biological active compounds from plants in research settings. Methanol extracted more compounds followed by acetone, then ethyl acetate and n-hexane the least. The constituents extracted by methanol may be mostly sugars, amino acids and glycosides due to the polarity of this solvent. Hydro-alcoholic solvents extract a variety of compounds that are mostly polar. Acetone extracts mostly alkaloids, aglycones and glycosides while n-hexane in general extracts mostly waxes, fats and fixed oils. High yield was obtained with leaf extracts with all the solvent used for extraction as compared to the root. The TLC finger-print showed that good separation was achieved with the methanol and acetone extracts in CEF mobile phase, ethyl acetate extracts in CEF and EMW and n-hexane extracts in BEA respectively, especially with the leaf extract. Most compounds present in S. italica extracts were UV active. Some compounds that were not reactive with vanillin-H2SO4 reagent were shown to be reactive with p-anisaldehyde reagent and iodine vapour which revealed the presence of sugars or aromatic compounds. Chemical analysis for secondary metabolites of the acetone root and leaf extracts revealed the presence of flavonoids, terpenes, tannins, steroids, reducing sugars and alkaloids while glycosides were detected only in the leaf extract. The results obtained using TLC analyses were consistent with the results obtained in the chemical analysis. Thin layer chromatography revealed the presence of glycoflavones in the acetone root extract, alkaloids in the root and leaf extracts; and phytosterols and flavonoid aglycones in root and leaf extracts. The acetone root and leaf extracts revealed the presence of phenols. The leaf extract was shown to contain high total phenolic content as compared to the root. The methanol and acetone root and leaf extracts were shown to possess antioxidant activity. However, the concentration of the activity was higher in the acetone root than in the leaf extract. The least activity was observed with the ethyl acetate root and leaf extracts as compared to other extracts. The n-hexane extracts however, was not shown to contain any antioxidant compounds. Although activity observed with the methanol extracts was comparable to that of the acetone extracts in the quantitative assay, the acetone extracts were shown to possess more antioxidant activity in the qualitative assay. The concentration of extracts increased with increase in scavenging activity. The root extract exhibited a more potent antioxidant activity compared to leaf extract. These extracts were evaluated for their cytotoxicity on normal cells. The highest cytotoxic concentration (CC50) was obtained with the root extract with a CC50 value of 297 635 μg/ml at 48 hrs, followed by CC50 value of 21 544 μg/ml at 24 hrs. The CC50 value of the leaf extract at 24 hrs was 2 904 μg/ml with the least value at 48 hrs. The root extract at 24 and 48 hrs together with the leaf extract at 24 hrs were not toxic to C2C12 muscle cells at the concentration tested in this study. The acetone extracts were shown to possibly enhance proliferation of C2C12 muscle cells at a concentration of 0.001–1000 μg/ml. The non-cytotoxic concentration of 25 μg/ml of the leaf extract in combination with insulin showed more glucose uptake as compared to other extracts as well as the control. Prolonged incubation time was shown to increase glucose uptake with leaf extract while increase in concentration of root extract decreased glucose uptake at 24 hrs. At incubation time of 3 and 24 hrs, glucose uptake results at concentration of 2.5 μg/ml were comparable with that of the root extract, with a similar trend observed at 25 μg/ml, although with decrease in uptake. The qualitative and quantitative fluorescence results showed GLUT4 to be translocated to the cell membrane. The leaf extract at a concentration of 25 μg/ml had more fold as compared to other extracts, indicative that more GLUT4 was translocated at this concentration of the leaf extract. The acetone root and leaf extracts were shown to increase protein expression of GLUT4 at 3 hrs incubation time as compared to other incubation times in insulin-stimulated C2C12 muscle cells. The plant constituents of S. italica was shown to contain a variety of secondary metabolites that maybe be acting alone or in concert with each other to exert the various activities observed in this study. Different solvents used for extraction may be responsible for the extraction of different constituents with antioxidant activity observed in the study. The acetone extracts enhanced proliferation of C2C12 muscle cells at concentrations used in the study. However, there was no significant reduction on viability of normal cells. In addition, the extracts were shown to enhance the differentiation of NIH-3T3-L1 preadipocytes into adipocytes and C2C12 muscle cells into myocytes. These in turn induced the translocation of GLUT4 to the cell membrane and as a consequence facilitate glucose transport. Hence, the differentiation of adipose cells as well as glucose uptake of muscle cells and GLUT4 expression might have been enhanced by constituents contained in the acetone extracts. In conclusion, the acetone leaf extract may have a beneficial role in glucose metabolism of differentiated C2C12 muscle cells. Therefore, further studies are however required to elucidate the molecular mechanism by which the acetone leaf extract of S. italica influences the translocation of GLUT4.
|
64 |
近十年(1999年-2009年)支氣管哮喘針灸治療刺灸劑量的文獻定量研究鄭康立, 01 January 2011 (has links)
No description available.
|
65 |
针灸治疗支气管哮喘的免疫学机制张维, 01 January 2008 (has links)
No description available.
|
66 |
SpacefulnessLegefors, Linnea January 2019 (has links)
How can space create qualities that evoke spatial contemplation, exploration and sensory stimulation to create consciousness and spaces for healing and well being? The fast paced lives, new technology and the constant connection today is leading to stress and anxiety and takes hold of one’s ability to remain present. It has been a change in the fundamentals of the human experience. Our use of technology is creating a two dimensional world, where we´re experiencing the world through the phone, tv or computer which has replaced the experience through the body and all of its senses. Stress narrows our attention and our connection to the present moment and personal encounters. So how can space then instead create consciousness so that we become aware and mindful in the present moment? By emphasising the path to our destination, we can make the arrow longer between point A and point B. This can be done by using different types of mens to heighten the sensory experience acoustically, tactilely and visually. We can see the path we think we are going to take to get to the goal, but along the way we meander, we engage, we stop and touch the wall, we feel the light filter into the space, we pause in the warmth that is created from the ambience, we hear the sound from dripping water. These are perhaps the more memorable experiences. Not the goal but the way there itself.
|
67 |
The effects of alternative treatment strategies to increase production and reduce the severity of parasitic infection in sheepCampbell, Braden Joseph 06 September 2017 (has links)
No description available.
|
68 |
The effect of OsteoEze Gold™ on pain and functional ability in osteoarthritis of the kneeMacquilkan, Kim Elizabeth 10 June 2014 (has links)
M.Tech. (Homoeopathy) / Osteoarthritis (OA) is a musculoskeletal condition affecting the synovial joints of the body, most commonly the knee and hip (Colledge et al., 2010). OA is the most prevalent joint disorder worldwide (Ickinger & Tikly, 2010). The prevalence of OA of the knee in developing countries, including South Africa, is expected to increase due to the increase in obesity and life-expectancy (Woolf & Pfleger, 2003). OA not only impacts negatively on many areas of the patient’s personal life, but it also has a considerable impact on health care systems and cost to the patient (Lapsley et al., 2001; Majani et al., 2005). The two main complaints in patients suffering from OA of the knee are knee pain and decreased daily functionality, such as walking (Samson et al., 2007). The main aim of conventional treatment is pain reduction. This treatment does not prevent progression of the OA, and may have negative side-effects (Day & Graham, 2005). Treatments for OA, such as OsteoEze GoldTM, may provide an effective and safer alternative. The aim of this study is to determine the effect of OsteoEze GoldTM on pain and functional ability in osteoarthritis of the knee using the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale: knee version (Appendix D) and the Short Physical Performance Battery (SPPB) test (Appendix E). This was a 16-week study, conducted at the Homoeopathic Health Centre, Doornfontein campus (DFC), University of Johannesburg (UJ). The study was randomised, double blind placebo controlled, and matched pairs were utilised. Sixty-seven participants, who satisfied the inclusion and exclusion criteria, were recruited, and 48 of the participants completed the study. Participants were recruited by advertisements, placed in and around the UJ Homoeopathy Health Centre (with relevant permission given) and by word of mouth. The participants were split into two groups using matched pairs according to age, gender and severity of symptoms (Appendix H). The participants in group A received the OsteoEze GoldTM capsules, and the participants in group B received the placebo capsules. Each capsule of OsteoEze GoldTM contained 500mg glucosamine sulphate, 267mg of chondroitin sulphate, 50mg of vitamin C and 1mg of manganese. The OsteoEze GoldTM or the placebo capsules were distributed at the initial (week-0) and second (week-8) consultations.
|
69 |
Effects of some Chinese herbs on bone metabolism: osteoporosis and bone healing. / CUHK electronic theses & dissertations collectionJanuary 2013 (has links)
傳統中醫中藥理論遵從"腎主骨"概念。因此,中醫在治療與骨有關的疾病時一般都處方"補腎"類中藥。 / ELP是一例中藥草本 "補腎" 複方。其包含三種中藥,包括淫羊藿(E)、女貞子(L)和補骨脂(P)。動物體內實驗和臨床研究已證明ELP有效治療絶經後骨質疏鬆症。可是,經口服吸收後的血清中的ELP有效物質對細胞的成骨影響從未進行過相關研究。ELP對預防在缺乏體力活動下所引起的骨質疏鬆症的療效也屬未知。此外,基於其"補腎"的特性,ELP可能潛在著能促進骨折癒合的功能。本研究的目的包括研究血清中ELP的有效物質在細胞和分子水平上的護骨能力,並測試其對預防於失重狀態下引起的骨質疏鬆症(慢性骨紊亂)的效能。本研究還旨在考察 ELP在促進骨癒合 (急性骨紊亂)上的作用。本研究分為三部分。 / 第一部分 -- 骨代謝的體外研究:健康大鼠分別口服草本配方ELP、EL、及單味中草藥提取物E或L、並以蒸餾水作為對照(H2O),口服給藥二小時後收集其血清作體外血清藥理學研究。分別考察含藥血清對各細胞系包括UMR106、RAW264.7、和從大鼠骨中分離出的骨髓間充質幹細胞(MSC)的增殖和分化屬性的影響,並以液質聯用技術(LC-MS)來分析血清內所含中藥的化學成份。 / 第二部分 -- 骨質疏鬆症的體內研究:以尾吊雄性大鼠作為卸荷狀態骨質疏鬆症的動物模型。在不同的給藥組中,大鼠口服高中低三種劑量的ELP(ELP-H、ELP-M和ELP-L),或三個不同抗骨質疏鬆藥物,包括雷洛昔芬(Ral),阿侖膦酸鈉(Aln)和雷奈酸鍶(Strn)作為陽性對照組,並以蒸餾水為安慰劑對照(TS)。另一組大鼠則沒有尾吊,作為正常對照(Non-TS)。本部分分析在吊尾期間大鼠體內生化指標和骨密度(BMD)的變化,及其後各組在骨小梁微結構和骨骼生物力學上的差異。 / 第三部分 -- 骨缺損癒合的體內研究:兩個鑽孔性骨缺損模型分別建立於老年雌性大鼠的左股骨骨幹和右脛骨近端骺端。其後動物分成4組:(1)ELP 口服給藥(ELP);(2)CDNR外敷治療(CDNR為另一中藥複方,包含紅花(C)、續斷(D)、三七(N)和大黃(R));(3)ELP口服給藥結合CDNR外敷治療(ELP+CDNR);(4)和蒸餾水餵養(Control)。通過監測骨缺損癒合的過程、檢測大鼠血液中生化標誌物的變化、骨骼生物力學測試和形態計量學分析,考察ELP及其與CDNR在骨缺損癒合上的協同作用。 / 第一部分的結果顯示,口服給藥二小時後,大鼠血清中淫羊藿的標記化合物淫羊藿苷(icariin)無被檢出。在EL或E的給藥大鼠血清中,檢出淫羊藿苷的其中一個代謝產物icariside I;而其另一個代謝產物icariside II,則在ELP的給藥大鼠血清中檢測到。L和P的常見標記化合物則能從相應餵飼L和P的大鼠血清中檢出。體外血清藥理學研究結果表明含藥(ELP)大鼠血清對細胞無毒性作用,且能促進 UMR106 細胞增殖和上調其Runx2 基因表達。然而,含藥血清無增加UMR106細胞的鹼性磷酸酶活性和鈣沉積。它抑制 RAW264.7細胞的分化及其基質金屬蛋白酶9(MMP-9)和組織蛋白酶 K的基因表達。它亦能促進MSC細胞的增殖,增強其鹼性磷酸酶活性和Runx2與ALP基因的表達。 / 第二部分的結果指出ELP-H能減少吊尾大鼠股骨遠端及腰椎骨密度的百分比損失,抵抗股骨遠端骨小梁微結構惡化和加強股骨骨幹骨缺損部位的生物力學特性。此外,ELP-H還能降低血液骨鈣素和抗酒石酸酸性磷酸酶5b(TRAP5b)的濃度。研究亦發現ELP對骨密度、結構參數和生化指標的影響存在劑量依賴性。整體上而言,ELP在預防卸荷骨質疏鬆症的影響類似於Ral和Aln,而非Strn。 / 第三部分的結果表明,從顯微電腦掃描或形態計量學上分析,所有實驗組跟對照組間均沒有顯著性差異。但值得注意的是,ELP+CDNR大大提高了股骨骨幹骨缺損在癒合過程中的歸一化生物力學屬性。而ELP單獨用藥則減少了TRAP5b的濃度。 / 總之,這項研究結論出血清藥理學研究加上LC-MS的應用能作為找出中藥中有效成分的有效途徑。本研究還展示ELP的含藥血清對骨細胞有護骨作用。ELP可防預在卸荷狀態下形成的骨質疏鬆症,它還有助於提升外敷中藥複方CDNR在骨缺損癒合過程中的療效。從這項研究的三個部分中歸納出的共同點說明,儘管ELP擁有刺激成骨的能力,它的護骨作用主要是透過它的抗骨吸收效果。ELP在慢性(防止骨質疏鬆症)和急性(促進骨癒合)骨紊亂上均有療效。 / Traditional Chinese Medicine (TCM) claims that bone health lies in the functioning of the "Kidneys". When the "Kidney" is strong, our body can stimulate growth and transformation of the bone marrow, which nourishes and strengthens the skeleton. Therefore, "Kindey-tonifying" herbs are usually used to cure bone diseases. / ELP is a "Kidney-tonifying" Chinese herbal formula containing three Chinese herbs including Herba Epimedii (E), Fructus Ligustri Lucidi (L) and Fructus Psoraleae (P). It has been proven effective to treat postmenopausal osteoporosis through in vivo and clinical studies. However, ELP is for oral administration. The osteogenic properties of its post-absorption metabolites have never been studied. The efficacy of ELP on prevention of osteoporosis development due to physical inactivity is also unknown. With its "Kindey-tonifying" property, ELP is also considered as a potential agent to facilitate fracture healing. / The aims of this study included to investigate the osteoprotective effects of ELP metabolites at cellular and molecular levels and to prove the efficacy of ELP on prevention of osteoporosis development in unloading condition - a chronic bone disorder. It also aimed to study the effect of ELP on promotion of bone defect healing - an acute bone disorder. This study was divided into three parts. / Part 1 - in vitro study of bone metabolism: Healthy rats were fed with herbal formula ELP or EL, single herbal extracts of E or L or distilled water as control (H₂O). Sera were then collected for in vitro seropharmacological study. Cell lines including UMR106 and RAW264.7, as well as mesenchymal stem cell (MSC) isolated from rats, were cultured with the sera. Their proliferation and differentiation properties of the cells were analyzed. In addition, the chemical profiles of the herbal extracts within the sera were analyzed using liquid chromatography-mass spectrometry (LC-MS). / Part 2 - in vivo study of osteoporosis: Tail-suspension male rats were used as the unloading osteoporotic animal model. The rats in different groups were fed with three different doses of ELP (ELP-H, ELP-M and ELP-L), or three different anti-osteoporosis drugs including raloxifene (Ral), alendronate (Aln) and strontium ranelate (Strn) as positive controls or distilled water as placebo control (TS). One group of rats was non-tail-suspended as normal control (Non-TS). Changes in bone mineral density (BMD), microarchitecture of trabeculae and biomechanical properties of the bone of the rats were analyzed. Changes in biochemical markers within the tail-suspension period were also studied. / Part 3 - in vivo study of bone defect healing: two drilled-hole bone defects were created in the diaphysis of left femur and proximal metaphysis of right tibia, respectively, of aged female rats. Animals were divided into 4 groups: (1) administered with ELP orally (ELP); (2) treated with another herbal formula CDNR containing Carthami Flos (C), Dipsaci Radix (D), Notoginseng Rhizoma (N) and Rhei Rhizoma (R) topically (CDNR); (3) treated with oral ELP and topical CDNR at the same time (ELP+CDNR); and (4) fed with distilled water (Control). The effects of ELP and the synergistic effects of ELP+CDNR on facilitation of the bone defect healing were monitored in vivo using viva-CT and through measurement of biochemical markers biweekly. After euthanasia of the rats, the bones were harvested for biomechanical test and histomorphometrical analysis. / Results: Part 1 revealed that the common marker compound, icariin, had not been detected in the sera of all the rats. Instead, one of the metabolites of E, icariside I, was found in the sera of the rats fed with EL or E, while another metabolite, icariside II, was detected in the serum of the rats fed with ELP. Common marker compounds of L and P were observed in the sera of the rats fed with the herbal items accordingly. The in vitro studies in this Part showed that there was no cytotoxic effect of the rat sera on the cells. The post-absorbed ELP metabolites in rat serum promoted UMR106 proliferation by 25.7%, (p < 0.05) and upregulated the Runx2 gene expression by 1.18 fold (p < 0.05) after cultured for 2 and 3 days, respectively. However, they could not increase the ALP activity and calcium deposition of UMR106. They also inhibited RAW264.7 differentiation by 29.2 % (p < 0.05) and downregulated the MMP9 and Cathepsin K gene expression of RAW264.7 by 0.46 (p < 0.05) and 0.36 (p < 0.01) fold, respectively. The ELP metabolites promoted the proliferation of MSC by 14.4 % (p < 0.001) and resulted in 42.6 % higher ALP activity than the control serum (p < 0.05). They also upregulated the Runx2 and ALP gene expression at both Day 4 and Day 7 of culture significantly. / Part 2 showed that compared with the tail-suspension control (TS), ELP in high dose (ELP-H) reduced the percentage loss of total and trabecular BMD by 5.46 and 8.52 %, respectively (p < 0.05 both) in distal femur, and by 4.67 % (p < 0.05) in trabecular region of lumbar spine of the tail-suspended rats. Analysis from micro-CT showed that microarchitectural parameters BV/TV, Tb.Th and TV density of the distal femur of ELP-H were 17.62, 11.90 and 8.09 % higher than those of the TS (p < 0.05, for all). 3-point bending test on mid-shaft femur of the rats revealed that the yield load, ultimate load and stiffness of the drill-defect of ELP-H were higher than those of TS significantly. All of the biochemical markers decreased significantly from baseline (Day 0) to Day 28 in ELP-H. In addition, osteocalcin and TRAP5b concentrations of ELP-H were lower than those of TS significantly at Day 28. The effect of ELP on BMD, microarchitectural parameters and biochemical markers were in dose-dependent manner. In general, the osteoprotective effect of ELP-H on unloading bone was similar to Ral and Aln, but not Strn. / Part 3 indicated no significant difference in BV/TV and BMD among all groups at each time point. Histomorphometrical analysis from fluorescent labeling and Goldner’s trichrome staining showed no statistical difference in new bone formation between the Control and other treatment groups. Notably, the normalized yield load, ultimate load and failure of ELP+CDNR were significantly higher than those of Control by 20.38 % (p < 0.05), 23.17 % (p< 0.001) and 25.55 % (p< 0.001), respectively. Analysis on the change of biochemical markers showed that the bone formation marker BALP increased while bone resorption markers Dpd and TRAP5b decreased within the 42-day monitoring period. BALP activity of both Control and ELP increased significantly but only ELP reduced the TRAP5b concentrations starting from Day 14 post-op. There was no statistical difference when the concentrations of the biochemical markers were compared horizontally among the 4 groups at the same time point. / In conclusion, the current study demonstrated that seropharmacological study incorporating with the application of LC-MS can be a potential efficient approach to find out active ingredients of medicine herbs. Post-absorbed metabolites of ELP also showed their osteoprotective effects on bone cells. Aqueous extract of ELP could prevent the development of osteoporosis in unloading condition and such effect was dose-dependent. It also helped elevating the efficacy of a topical applied herbal formula CDNR on improving the bone strength of healing bone defects. A common finding from the 3 parts of this study illustrated that the osteoprotective effect of ELP was mainly achieved by its anti-resorptive efficacy on bone, although it possess an ability to stimulate osteoblastogenesis. ELP was found effective for both chronic (prevent osteoporosis development) and acute (facilitate bone healing) bone disorders. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Siu, Wing Sum. / "November 2012." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2013. / Includes bibliographical references (leaves 201-227). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts also in Chinese. / ABSTRACT --- p.i / 摘要 --- p.vi / ACKNOWLEDGEMENTS --- p.ix / TABLE OF CONTENTS --- p.xi / LIST OF FIGURES --- p.xvii / LIST OF TABLES --- p.xxiii / PUBLICATIONS --- p.xxiv / ABBREVIATION --- p.xxv / Chapter CHAPTER 1: --- INTRODUCTION --- p.1 / Chapter 1.1 --- TRADITIONAL CHINESE MEDICINE (TCM) AND BONE DISEASES --- p.1 / Chapter 1.2 --- CELLULAR AND MOLECULAR MECHANISMS ON BONE METABOLISM --- p.2 / Chapter 1.2.1 --- Bone formation by osteoblast --- p.3 / Chapter 1.2.2 --- Bone resorption by osteoclasts --- p.4 / Chapter 1.3 --- OSTEOPOROSIS --- p.5 / Chapter 1.3.1 --- Postmenopausal osteoporosis --- p.6 / Chapter 1.3.2 --- Disuse osteoporosis --- p.8 / Chapter 1.3.3 --- Basic principle of TCM on osteoporosis --- p.10 / Chapter 1.3.4 --- Common Chinese herbal medicine reported to have anti-osteoporotic effects --- p.11 / Chapter 1.4 --- BONE FRACTURE --- p.11 / Chapter 1.4.1 --- Biology and repair of bone fracture --- p.12 / Chapter 1.4.2 --- TCM on promotion of fracture healing --- p.13 / Chapter 1.4.3 --- Theories of TCM on fracture healing --- p.15 / Chapter CHAPTER 2: --- OSTEOPOROSIS AND HERBS --- p.16 / Chapter 2.1 --- CHINESE HERBAL MEDICINE SELECTED IN THIS PART --- p.16 / Chapter 2.2 --- DESIGN OF STUDY --- p.19 / Chapter 2.3 --- HYPOTHESES AND OBJECTIVES --- p.19 / Chapter 2.4 --- BACKGROUND OF THE STUDY --- p.23 / Chapter 2.4.1 --- In vitro study of ELP on bone cells --- p.23 / Chapter 2.4.2 --- In vivo study of ELP on postmenopausal osteoporosis --- p.23 / Chapter 2.4.3 --- Clinical study of ELP on postmenopausal osteoporosis --- p.24 / Chapter CHAPTER 3: --- PART 1 IN VITRO SEROPHARMACOLOGICAL STUDY ON OSTEOPOROSIS --- p.26 / Chapter 3.1 --- OBJECTIVES --- p.26 / Chapter 3.2 --- SEROPHARMACOLOGICAL APPROACH TO STUDY ELP --- p.26 / Chapter 3.3 --- TYPES OF CELLS INVOLVED IN THE CURRENT STUDY --- p.27 / Chapter 3.3.1 --- UMR106 --- p.28 / Chapter 3.3.2 --- RAW264.7 --- p.28 / Chapter 3.3.3 --- Mesenchymal stem cell (MSC) --- p.28 / Chapter 3.4 --- IN VITRO ASSESSMENTS ON BONE METABOLISM --- p.29 / Chapter 3.4.1 --- Bone formation --- p.29 / Chapter 3.4.1.1 --- 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability assay --- p.29 / Chapter 3.4.1.2 --- Bromodeoxyuridine (BrdU) assay --- p.30 / Chapter 3.4.1.3 --- Total alkaline phosphatase (ALP) activity measurement --- p.30 / Chapter 3.4.1.4 --- Calcium deposition analysis --- p.30 / Chapter 3.4.2 --- Bone degradation --- p.31 / Chapter 3.4.2.1 --- Tartrate-resistant acid phosphatase (TRAP) staining --- p.31 / Chapter 3.4.3 --- Phenotypic markers of cells involved in bone remodeling using quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) --- p.31 / Chapter 3.5 --- MATERIAL AND METHODS --- p.37 / Chapter 3.5.1 --- Preparation of herbal extracts --- p.37 / Chapter 3.5.2 --- Serum preparation for seropharmacological study --- p.38 / Chapter 3.5.2.1 --- Administration of herbal extracts and blood collection --- p.38 / Chapter 3.5.2.2 --- Serum preparation --- p.38 / Chapter 3.5.3 --- Analysis of marker compounds in serum using liquid chromatographymass spectrometry (LC-MS) --- p.39 / Chapter 3.5.3.1 --- Serum preparation --- p.39 / Chapter 3.5.3.2 --- Operation of LC-MS --- p.39 / Chapter 3.5.4 --- Isolation and characterization of MSC from bone marrow --- p.40 / Chapter 3.5.5 --- Cell culture --- p.42 / Chapter 3.5.5.1 --- General materials --- p.42 / Chapter 3.5.5.2 --- UMR106 --- p.43 / Chapter 3.5.5.3 --- RAW264.7 --- p.44 / Chapter 3.5.5.4 --- Bone Marrow MSC --- p.45 / Chapter 3.5.6 --- Assays analyzing the responses of cells on the effect of metabolites of herbs in serum --- p.46 / Chapter 3.5.6.1 --- General materials --- p.46 / Chapter 3.5.6.2 --- Assays for bone formation --- p.50 / Chapter 3.5.6.3 --- Assays for bone degradation --- p.55 / Chapter 3.5.7 --- Statistical analysis --- p.56 / Chapter 3.6 --- RESULTS --- p.57 / Chapter 3.6.1 --- Chemical characterization of ELP extract --- p.57 / Chapter 3.6.2 --- Marker compounds found in rat serum using LC-MS --- p.58 / Chapter 3.6.3 --- Effects of herbal metabolites on UMR106 --- p.61 / Chapter 3.6.3.1 --- Effect on cell viability --- p.61 / Chapter 3.6.3.2 --- Effects on cell proliferation and differentiation --- p.61 / Chapter 3.6.3.3 --- Regulation on osteogenesis through gene expression --- p.63 / Chapter 3.6.4 --- Effects of herbal metabolites on RAW264.7 --- p.67 / Chapter 3.6.4.1 --- Effect on cell viability --- p.67 / Chapter 3.6.4.2 --- Inhibitory effect on RAW264.7 --- p.67 / Chapter 3.6.4.3 --- Regulation on osteoclastogenesis through gene expression --- p.67 / Chapter 3.6.5 --- Effects of herbal metabolites on bone marrow mesenchyma stem cell (MSC) --- p.70 / Chapter 3.6.5.1 --- Confirmation of MSC isolated from bone marrow of rat using flow cytometry --- p.70 / Chapter 3.6.5.2 --- Effect on cell viability --- p.70 / Chapter 3.6.5.3 --- Effects on cell proliferation and differentiation --- p.71 / Chapter 3.6.5.4 --- Regulation on osteogenesis through gene expression --- p.71 / Chapter 3.7 --- DISCUSSION --- p.75 / Chapter CHAPTER 4: --- PART 2 IN VIVO STUDY ON DISUSE OSTEOPOROSIS . --- p.83 / Chapter 4.1 --- OBJECTIVES --- p.83 / Chapter 4.2 --- POTENTIAL EFFECT OF ELP ON DISUSE OSTEOPOROSIS --- p.83 / Chapter 4.3 --- ANIMAL MODELS FOR OSTEOPOROSIS STUDY --- p.84 / Chapter 4.3.1 --- Conventional ovariectomized animal model for the studies of osteoporosis --- p.85 / Chapter 4.3.2 --- Animal models for study of disuse osteoporosis --- p.85 / Chapter 4.3.2.1 --- Bandaging or casting --- p.86 / Chapter 4.3.2.2 --- Tail-suspension (TS) --- p.86 / Chapter 4.4 --- ASSESSMENTS ON DISUSE OSTEOPOROSIS DEVELOPMENT --- p.87 / Chapter 4.4.1 --- Bone mineral density (BMD) measurement --- p.87 / Chapter 4.4.2 --- Micro-architecture analysis --- p.87 / Chapter 4.4.3 --- Bone strength assessment --- p.88 / Chapter 4.4.4 --- Bone turnover monitoring by measuring biochemical markers --- p.89 / Chapter 4.4.4.1 --- Bone formation markers --- p.89 / Chapter 4.4.4.2 --- Bone resorption markers --- p.91 / Chapter 4.5 --- MATERIAL AND METHODS --- p.95 / Chapter 4.5.1 --- Preparation of herbal extracts --- p.95 / Chapter 4.5.2 --- Tail-suspension rat model --- p.95 / Chapter 4.5.3 --- Animal arrangement and grouping --- p.97 / Chapter 4.5.4 --- Administration of herbal extracts and drugs --- p.97 / Chapter 4.5.5 --- Assessments on disuse osteoporosis development --- p.98 / Chapter 4.5.5.1 --- Bone mineral density measurement using Peripheral Quantitative Computed Tomography (pQCT) --- p.98 / Chapter 4.5.5.2 --- Bone micro-architecture analysis using Micro-computed Tomography (μCT) --- p.99 / Chapter 4.5.5.3 --- Bone strength assessment through biomechanical bending test --- p.100 / Chapter 4.5.5.4 --- Bone turnover monitoring by measuring biochemical markers --- p.100 / Chapter 4.5.5.4.1 --- Serum collection --- p.100 / Chapter 4.5.5.4.2 --- Measurements of biochemical markers --- p.101 / Chapter 4.5.6 --- Statistical analysis --- p.105 / Chapter 4.6 --- RESULTS --- p.106 / Chapter 4.6.1 --- Effects of ELP on bone mineral density (BMD) --- p.106 / Chapter 4.6.2 --- Effects of ELP on bone micro-architecture --- p.118 / Chapter 4.6.3 --- Effects of ELP on biomechanics of bone --- p.122 / Chapter 4.6.4 --- Effects of ELP on bone turnover --- p.125 / Chapter 4.7 --- DISCUSSION --- p.132 / Chapter CHAPTER 5: --- PART 3 IN VIVO STUDY ON BONE DEFECT HEALING --- p.140 / Chapter 5.1 --- HERBAL ITEMS SELECTED IN THIS PART --- p.140 / Chapter 5.2 --- DESIGN OF STUDY --- p.143 / Chapter 5.3 --- HYPOTHESES AND OBJECTIVES --- p.144 / Chapter 5.4 --- SPECIFIC STRATEGY ON PROMOTION OF FRACTURE HEALING OF TCM --- p.144 / Chapter 5.5 --- POTENTIAL EFFECT OF ELP ON BONE HEALING --- p.144 / Chapter 5.6 --- ANIMAL MODELS --- p.146 / Chapter 5.6.1 --- Bone fracture model --- p.147 / Chapter 5.6.2 --- Drill-hole bone defect model --- p.147 / Chapter 5.7 --- ASSESSMENTS ON BONE HEALING --- p.149 / Chapter 5.7.1 --- Micro-architecture analysis --- p.149 / Chapter 5.7.2 --- Bone strength assessment --- p.150 / Chapter 5.7.3 --- Bone turnover monitoring by measuring biochemical markers --- p.151 / Chapter 5.7.4 --- Histomorphometry --- p.151 / Chapter 5.8 --- MATERIALS AND METHODS --- p.153 / Chapter 5.8.1 --- Preparation of herbal extracts --- p.153 / Chapter 5.8.1.1 --- ELP --- p.153 / Chapter 5.8.1.2 --- CDNR --- p.153 / Chapter 5.8.2 --- Production of drill-hole bone defect --- p.154 / Chapter 5.8.2.1 --- Femur --- p.155 / Chapter 5.8.2.2 --- Tibia --- p.155 / Chapter 5.8.2.3 --- Animal arrangement and grouping --- p.157 / Chapter 5.8.3 --- Herbal formulae administration and application --- p.157 / Chapter 5.8.3.1 --- Oral administration --- p.157 / Chapter 5.8.3.2 --- Topical application --- p.157 / Chapter 5.8.4 --- Assessments on bone healing --- p.158 / Chapter 5.8.4.1 --- Bone micro-architecture and bone density measurement using in vivo micro-computed tomography (vivaCT) --- p.158 / Chapter 5.8.4.2 --- Bone strength assessment through biomechanical bending test --- p.159 / Chapter 5.8.4.3 --- Bone turnover monitoring by measuring biochemical markers --- p.160 / Chapter 5.8.4.4 --- Histomorphometry --- p.160 / Chapter 5.8.4.4.1 --- Fluorochrome double labeling --- p.160 / Chapter 5.8.4.4.2 --- Tissue processing and sectioning --- p.161 / Chapter 5.8.4.4.3 --- Staining of sections --- p.162 / Chapter 5.8.4.4.4 --- Image analysis --- p.164 / Chapter 5.8.5 --- Statistical analysis --- p.165 / Chapter 5.9 --- RESULTS --- p.166 / Chapter 5.9.1 --- Effect of ELP and CDNR on bone micro-architecture --- p.and / Chapter bone --- density at the bone defect site --- p.166 / Chapter 5.9.2 --- Histomorphometrical findings in treatment of bone healing --- p.172 / Chapter 5.9.3 --- Effect of ELP and CDNR on biomechanics of bone --- p.175 / Chapter 5.9.4 --- Effect of ELP and CDNR on bone turnover --- p.178 / Chapter 5.10 --- DISCUSSION --- p.184 / Chapter CHAPTER 6: --- GENERAL DISCUSSION AND CONCLUSION --- p.193 / Chapter 6.1 --- UNKNOWN AREAS FOR THE STUDY OF ELP --- p.193 / Chapter 6.2 --- SUMMARY OF CRUCIAL FINDINGS OF THE OSTEOGENIC EFFECTS OF ELP IN EACH PART OF THIS STUDY --- p.194 / Chapter 6.2.1 --- Part 1: in vitro seropharmacological study on osteoporosis --- p.194 / Chapter 6.2.2 --- Part 2: in vivo study on disuse osteoporosis --- p.195 / Chapter 6.2.3 --- Part 3: in vivo study on bone healing --- p.196 / Chapter 6.3 --- COMMON OSTEOGENIC EFFECT OF ELP IN THE THREE PARTS OF THE WHOLE STUDY --- p.197 / Chapter 6.4 --- LIMITATIONS OF THE PRESENT STUDY --- p.197 / Chapter 6.5 --- SIGNIFICANCES OF THIS STUDY --- p.199 / Chapter 6.6 --- FUTURE STUDIES --- p.199 / BIBLIOGRAPHY --- p.201
|
70 |
An exploratory study for the health seeking pattern of stroke survivors on alternative medicineMan, Lai-mei., 文麗媚. January 1998 (has links)
published_or_final_version / Social Work and Social Administration / Master / Master of Social Sciences
|
Page generated in 0.1081 seconds